|Articles|April 12, 2012
J&J hit with $1.2 Billion Penalty in Drug Case
Advertisement
An Arkansas judge slapped Johnson & Johnson and a subsidiary with more than $1.2 billion in penalties on Wednesday for deceptive marketing of the antipsychotic drug Risperdal.
The ruling marks the latest legal headache for J&J over the drug. Johnson & Johnson has faced lawsuits in a total of 11 states in connection with Risperdal.
Read the full story:
Source: CNN Money
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
What Comes Next: Taking on Unanswered Questions in Multiple Myeloma
2
Early-Life, Parental Factors May Help Explain Rising Early-Onset CRC Rates
3
COVID-19 May Follow A Different Seasonal Pattern Than Influenza, RSV
4
Treatment for Thyroid Eye Disease Approved by FDA
5